Case number 2023-1110
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 22, 2024 | 78 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [985602] [MVH] [Entered: 02/22/2024 10:53 AM] (1) |
| Jan 21, 2024 | 0 | EAGLE PHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Jan 17, 2024 | 77 | ORDER striking attorney entry of appearance [68], [66] for Joshua Miller. Service as of this date by the Clerk of Court. [977091] [MVH] [Entered: 01/17/2024 01:09 PM] (1) |
| Jan 16, 2024 | 76 | Corrected Certificate of Interest for Appellee Slayback Pharma LLC. Service: 01/16/2024 by email. [976750] [23-1110] [Constance Huttner] [Entered: 01/16/2024 01:42 PM] (3) |
| Jan 16, 2024 | 75 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [976661] [MVH] [Entered: 01/16/2024 10:26 AM] (2) |
| Jan 10, 2024 | 74 | Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Prost, Circuit Judge and Reyna, Circuit Judge.Arguing counsel: Gregory G. Garre for Eagle Pharmaceuticals, Inc., Constance Huttner for Slayback Pharma LLC and Eric Thomas Werlinger for Apotex Inc. and Apotex Corp..Oral Argument Audio available here. [975895] [MJL] [Entered: 01/10/2024 03:30 PM] (0) |
| Jan 9, 2024 | 73 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Slayback Pharma LLC, Amended Certificate of Interest [70], is not in compliance with the rules of this court (see attached). Compliant document due on 01/17/2024. Service as of this date by the Clerk of Court. [975449] [MVH] [Entered: 01/09/2024 12:33 PM] (1) |
| Jan 9, 2024 | 72 | Amended Response to notice of oral argument from Appellees Apotex Inc. and Apotex Corp.. Service: 01/09/2024 by email. [975420] [23-1110] [Eric Werlinger] [Entered: 01/09/2024 11:44 AM] (1) |
| Jan 9, 2024 | 71 | Amended Response to notice of oral argument from Appellee Slayback Pharma LLC. Service: 01/09/2024 by email. [975393] [23-1110] [Constance Huttner] [Entered: 01/09/2024 10:48 AM] (1) |
| Jan 8, 2024 | 70 | Amended Certificate of Interest for Appellee Slayback Pharma LLC. Service: 01/08/2024 by email. [975280] [23-1110]. This document is non-compliant. See Doc. No. [73] [Constance Huttner] [Entered: 01/08/2024 06:36 PM] (3) |
| Jan 5, 2024 | 69 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Slayback Pharma LLC, Entry of Appearance [68], is not in compliance with the rules of this court (see attached). Compliant document due on 01/12/2024. Service as of this date by the Clerk of Court. [974926] [MVH] [Entered: 01/05/2024 04:49 PM] (1) |
| Jan 5, 2024 | 68 | Corrected Entry of Appearance for Joshua I. Miller, Esq. as counsel for Appellee Slayback Pharma LLC. Service: 01/05/2024 by email. [974856] [23-1110]. This document is non-compliant. See Doc. No. [69]. Stricken pursuant to the court's order. See Doc. No. [77] [Joshua Miller] [Entered: 01/05/2024 03:08 PM] (0) |
| Jan 4, 2024 | 67 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Slayback Pharma LLC, Entry of Appearance [66], is not in compliance with the rules of this court (see attached). Compliant document due on 01/11/2024. Service as of this date by the Clerk of Court. [974435] [MVH] [Entered: 01/04/2024 09:33 AM] (2) |
| Jan 3, 2024 | 66 | Entry of Appearance for Joshua I. Miller as counsel for Appellee Slayback Pharma LLC. Service: 01/03/2024 by email. [974419] [23-1110]. This document is non-compliant. See Doc. No. [67]. Stricken pursuant to the court's order. See Doc. No. [77] [Joshua Miller] [Entered: 01/03/2024 06:21 PM] (0) |
| Dec 12, 2023 | 65 | Corrected Response to notice of oral argument from Appellee Slayback Pharma LLC. Service: 12/12/2023 by email. [969743] [23-1110] [Constance Huttner] [Entered: 12/12/2023 05:28 PM] (1) |
| Dec 12, 2023 | 64 | Response to notice of oral argument from Appellee Slayback Pharma LLC. Service: 12/12/2023 by email. [969708] [23-1110] [Constance Huttner] [Entered: 12/12/2023 04:36 PM] (1) |
| Dec 12, 2023 | 63 | Corrected Response to notice of oral argument from Appellees Apotex Inc. and Apotex Corp.. Service: 12/12/2023 by email. [969649] [23-1110] [Eric Werlinger] [Entered: 12/12/2023 03:28 PM] (1) |
| Dec 8, 2023 | 62 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Appellees' responses to notice of oral argument (RNOAs) [60] and [61] collectively designate 30 minutes of argument time. Each side is only authorized 15 minutes, which must be divided amongst arguing counsel on the same side. CORRECTION: Apellees must file a corrected RNOA for a single arguing counsel or corrected RNOAs for up to two counsel dividing the 15 minutes no later than 12/12/2023. [968717] [MJL] [Entered: 12/08/2023 10:03 AM] (0) |
| Dec 1, 2023 | 61 | Response to notice of oral argument from Appellees Apotex Inc. and Apotex Corp.. Service: 12/01/2023 by email. [967152] [23-1110] [Eric Werlinger] [Entered: 12/01/2023 05:46 PM] (2) |
| Dec 1, 2023 | 60 | Response to notice of oral argument from Appellee Slayback Pharma LLC. Service: 12/01/2023 by email. [967044] [23-1110] [Constance Huttner] [Entered: 12/01/2023 02:44 PM] (1) |
| Nov 30, 2023 | 59 | Response to notice of oral argument from Appellant Eagle Pharmaceuticals, Inc.. Service: 11/30/2023 by email. [966768] [23-1110] [Gregory Garre] [Entered: 11/30/2023 04:56 PM] (1) |
| Nov 17, 2023 | 58 | NOTICE OF ORAL ARGUMENT. Panel: 2401E. Case scheduled January 10, 2024. Response to Notice of Oral Argument due: 12/01/2023. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [964242] [MJL] [Entered: 11/17/2023 04:57 PM] (2) |
| Sep 12, 2023 | 57 | The following conflict dates submitted by Constance Huttner for Slayback Pharma LLC have been accepted by the court: 02/05/2024, 02/06/2024, 02/07/2024, 02/08/2024, 02/09/2024. [949437] [MJL] [Entered: 09/12/2023 01:00 PM] (0) |
| Sep 12, 2023 | 56 | The following conflict dates submitted by Gregory G. Garre for Eagle Pharmaceuticals, Inc. have been accepted by the court: 12/04/2023, 12/05/2023, 12/06/2023, 12/07/2023, 12/08/2023. The following conflict dates are not accepted at this time: 11/07/2023, 11/08/2023. [949435] [MJL] [Entered: 09/12/2023 12:58 PM] (0) |
| Sep 12, 2023 | 55 | The following conflict dates submitted by Deepro Mukerjee for Apotex Inc. and Apotex Corp. have been accepted by the court: 11/07/2023, 04/03/2024, 04/04/2024, 04/05/2024. The remaining dates do not fall within the court's scheduled sessions and are therefore not accepted. [949434] [MJL] [Entered: 09/12/2023 12:55 PM] (0) |
| Sep 6, 2023 | 54 | Notice from Appellee Slayback Pharma LLC regarding conflicts with oral argument. Service: 09/06/2023 by email. [948215] [23-1110] [Constance Huttner] [Entered: 09/06/2023 06:06 PM] (3) |
| Sep 6, 2023 | 53 | Notice from Appellant Eagle Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 09/06/2023 by email. [948182] [23-1110] [Gregory Garre] [Entered: 09/06/2023 04:51 PM] (3) |
| Sep 6, 2023 | 52 | Notice from Appellees Apotex Inc. and Apotex Corp. regarding conflicts with oral argument. Service: 09/06/2023 by email. [948144] [23-1110] [Deepro Mukerjee] [Entered: 09/06/2023 04:00 PM] (3) |
| Aug 30, 2023 | 51 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [946863] [ALK] [Entered: 08/30/2023 03:31 PM] (1) |
| May 18, 2023 | 50 | Notice from Appellant Eagle Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 05/18/2023 by email. [924392] [23-1110] [Gregory Garre] [Entered: 05/18/2023 02:16 PM] (3) |
| May 17, 2023 | 49 | Notice from Appellant Eagle Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 05/17/2023 by email. [924009] [23-1110] [Gregory Garre] [Entered: 05/17/2023 10:54 AM] (3) |
| Mar 23, 2023 | 48 | The following conflict dates submitted by Deepro Mukerjee for Apotex Inc. and Apotex Corp. have been accepted by the court: 05/01/2023, 05/02/2023, 05/03/2023, 05/04/2023, 05/05/2023, 06/05/2023, 06/06/2023, 06/07/2023, 06/08/2023, 06/09/2023. [911795] [MJL] [Entered: 03/23/2023 09:53 AM] (0) |
| Mar 20, 2023 | 47 | Notice from Appellee Slayback Pharma LLC regarding conflicts with oral argument. Service: 03/20/2023 by email. [911114] [23-1110] [Constance Huttner] [Entered: 03/20/2023 09:29 PM] (2) |
| Mar 20, 2023 | 46 | Notice from Appellees Apotex Inc. and Apotex Corp. regarding conflicts with oral argument. Service: 03/20/2023 by email. [911039] [23-1110] [Deepro Mukerjee] [Entered: 03/20/2023 04:08 PM] (3) |
| Mar 20, 2023 | 45 | This entry was made in error and has been removed from the docket. Clerk's Note to the File: The conflict dates are not accepted at this time. [911027]--[Edited 03/20/2023 by MJL to partially delete entry] [MJL] [Entered: 03/20/2023 03:58 PM] (0) |
| Mar 20, 2023 | 44 | The following conflict dates submitted by Gregory G. Garre for Eagle Pharmaceuticals, Inc. have been accepted by the court: 05/01/2023, 05/02/2023, 05/03/2023, 05/04/2023, 05/05/2023, 06/09/2023, 08/08/2023, 08/09/2023, 08/10/2023, 08/11/2023. [911025] [MJL] [Entered: 03/20/2023 03:56 PM] (0) |
| Mar 20, 2023 | 43 | Notice from Appellant Eagle Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 03/20/2023 by email. [910993] [23-1110] [Gregory Garre] [Entered: 03/20/2023 03:18 PM] (3) |
| Mar 16, 2023 | 41 | 6 paper copies of Doc. No. [38], [29], [20] received from Appellant Eagle Pharmaceuticals, Inc.. [910605] [VDW] [Entered: 03/17/2023 10:52 AM] (0) |
| Mar 15, 2023 | 42 | 6 paper copies of Doc. No. [27] received from Appellees Apotex Corp., Apotex Inc. and Slayback Pharma LLC. [910608] [VDW] [Entered: 03/17/2023 10:59 AM] (0) |
| Mar 13, 2023 | 40 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [909536] [KMH] [Entered: 03/13/2023 02:42 PM] (0) |
| Mar 13, 2023 | 39 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [909534] [KMH] [Entered: 03/13/2023 02:41 PM] (1) |
| Mar 3, 2023 | 38 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 03/03/2023 by email. [907804]--[Edited 03/13/2023 by KMH - compliance review complete] [Daniel Brown] [Entered: 03/03/2023 05:00 PM] (0) |
| Feb 28, 2023 | 37 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Eagle Pharmaceuticals, Inc., Confidential Appendix [35], is not in compliance with the rules of this court (see attached). Compliant document due on 03/07/2023. Service as of this date by the Clerk of Court. [906695] [KMH] [Entered: 02/28/2023 09:33 AM] (2) |
| Feb 17, 2023 | 36 | Notice from Appellee Slayback Pharma LLC Withdrawal of Counsel. Service: 02/17/2023 by email. [904845] [23-1110] [Constance Huttner] [Entered: 02/17/2023 01:15 PM] (5) |
| Feb 15, 2023 | 35 | CONFIDENTIAL APPENDIX FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 02/15/2023 by email. [904584] [23-1110] This document is non-compliant. See Doc No. [37] [Daniel Brown] [Entered: 02/15/2023 10:50 PM] (0) |
| Feb 15, 2023 | 34 | MODIFIED ENTRY: APPENDIX FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 02/15/2023 by email. [904583] --[Edited 02/28/2023 by KMH - compliance review complete] [Daniel Brown] [Entered: 02/15/2023 10:24 PM] (963) |
| Feb 15, 2023 | 33 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Eagle Pharmaceuticals, Inc.. Service: 02/15/2023 by email. [904576] [23-1110] [Daniel Brown] [Entered: 02/15/2023 08:30 PM] (2) |
| Feb 15, 2023 | 32 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Apotex Corp., Apotex Inc., Slayback Pharma LLC and Appellant Eagle Pharmaceuticals, Inc.. Service: 02/15/2023 by email. [904575] [23-1110] [Daniel Brown] [Entered: 02/15/2023 08:27 PM] (3) |
| Feb 15, 2023 | 31 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellee Slayback Pharma LLC. Service: 02/15/2023 by email. [904550] [23-1110] [Constance Huttner] [Entered: 02/15/2023 05:43 PM] (2) |
| Feb 15, 2023 | 30 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Apotex Inc. and Apotex Corp.. Service: 02/15/2023 by email. [904549] [23-1110] [Deepro Mukerjee] [Entered: 02/15/2023 05:32 PM] (3) |
| Feb 8, 2023 | 29 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 02/08/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [903011] --[Edited 02/13/2023 by KMH - compliance review complete] [Daniel Brown] [Entered: 02/08/2023 09:44 PM] (39) |
| Feb 8, 2023 | 28 | Amended Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 02/08/2023 by email. [903010] [23-1110] [Daniel Brown] [Entered: 02/08/2023 09:41 PM] (2) |
| Jan 26, 2023 | 27 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellees Apotex Corp., Apotex Inc. and Slayback Pharma LLC. Service: 01/26/2023 by email. [899858] --[Edited 01/31/2023 by KMH - compliance review complete] [Deepro Mukerjee] [Entered: 01/26/2023 11:27 AM] (84) |
| Jan 25, 2023 | 26 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Apotex Corp., Apotex Inc. and Slayback Pharma LLC, Response Brief [25], is not in compliance with the rules of this court (see attached). Compliant document due on 02/01/2023. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [899436] [KMH] [Entered: 01/25/2023 10:55 AM] (1) |
| Jan 18, 2023 | 25 | RESPONSE BRIEF FILED by Appellees Slayback Pharma LLC, Apotex Inc. and Apotex Corp.. Service: 01/18/2023 by email. [897820] [23-1110] This document is non-compliant. See Doc No. [26] [Deepro Mukerjee] [Entered: 01/18/2023 05:00 PM] (84) |
| Jan 18, 2023 | 24 | Amended Entry of Appearance for Deepro Mukerjee;Lance Soderstrom;Jitendra Malik;Joseph Janusz;Christopher Ferenc;Eric Thomas Werlinger;Timothy H. Gray as counsel for Appellees Apotex Inc. and Apotex Corp.. Service: 01/18/2023 by email. [897634] [23-1110] [Deepro Mukerjee] [Entered: 01/18/2023 12:12 PM] (3) |
| Jan 17, 2023 | 23 | Notice from Appellee Slayback Pharma LLC Withdrawal of Counsel. Service: 01/17/2023 by email. [897399] [23-1110] [Constance Huttner] [Entered: 01/17/2023 03:31 PM] (5) |
| Dec 19, 2022 | 22 | **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Appellees Apotex Inc., Apotex Corp. and Slayback Pharma LLC. The response brief is due 01/18/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [891318] [KMH] [Entered: 12/19/2022 09:35 AM] (0) |
| Dec 13, 2022 | 21 | MOTION of Appellees Slayback Pharma LLC, Apotex Inc. and Apotex Corp. to extend the time to 01/18/2023 to file brief. Service: 12/13/2022 by email. [890489] [23-1110] [Deepro Mukerjee] [Entered: 12/13/2022 07:05 PM] (13) |
| Dec 9, 2022 | 20 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 12/09/2022 by email. [889793] --[Edited 12/19/2022 by KMH - compliance review complete] [Daniel Brown] [Entered: 12/09/2022 06:27 PM] (111) |
| Dec 9, 2022 | 19 | Amended Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 12/09/2022 by email. [889790] [23-1110] [Daniel Brown] [Entered: 12/09/2022 06:22 PM] (2) |
| Dec 9, 2022 | 18 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Eagle Pharmaceuticals, Inc., Principal Brief of Appellant [15], is not in compliance with the rules of this court (see attached). Compliant document due on 12/16/2022. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [889711] [CAB] [Entered: 12/09/2022 03:14 PM] (2) |
| Nov 28, 2022 | 17 | Corrected Entry of Appearance for Constance S. Huttner; Roy Wepner; Jason Lief; Beth Finkelstein as counsel for Appellee Slayback Pharma LLC. Service: 11/28/2022 by email. [886563] [23-1110] [Constance Huttner] [Entered: 11/28/2022 09:52 AM] (2) |
| Nov 25, 2022 | 16 | Amended Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/25/2022 by email. [886527] [23-1110] [Daniel Brown] [Entered: 11/25/2022 10:36 PM] (2) |
| Nov 25, 2022 | 15 | OPENING BRIEF FILED by Appellant Eagle Pharmaceuticals, Inc.. Service: 11/25/2022 by email. [886526] [23-1110] This document is non-compliant. See Doc No. [18] [Daniel Brown] [Entered: 11/25/2022 10:31 PM] (111) |
| Nov 22, 2022 | 14 | Corrected Entry of Appearance for Daniel G. Brown;Gregory G. Garre;Gabriel K. Bell;Michael Clemente;David F. Kowalski as counsel for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/22/2022 by email. [886131] [23-1110] [Daniel Brown] [Entered: 11/22/2022 02:23 PM] (2) |
| Nov 22, 2022 | 13 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Eagle Pharmaceuticals, Inc. and Appellee Slayback Pharma LLC, Entry of Appearance [12], [2], is not in compliance with the rules of this court (see attached). Compliant document due on 12/01/2022. Service as of this date by the Clerk of Court. [885752] [KMH] [Entered: 11/22/2022 09:10 AM] (2) |
| Nov 21, 2022 | 12 | Corrected Entry of Appearance for Constance S. Huttner; Roy Wepner; Jason Lief; Beth Finkelstein as counsel for Appellee Slayback Pharma LLC. Service: 11/21/2022 by email. [885703] [23-1110] This document is non-compliant. See Doc No. [Constance Huttner] [Entered: 11/21/2022 08:56 PM] (2) |
| Nov 21, 2022 | 11 | Notice of Correction to Doc No. [5] for Appellee Slayback Pharma LLC. Service: 11/21/2022 by email. [885702] [23-1110] [Constance Huttner] [Entered: 11/21/2022 08:54 PM] (2) |
| Nov 16, 2022 | 10 | Docketing Statement for the Appellees Apotex Inc. and Apotex Corp.. Service: 11/16/2022 by email. [884510] [23-1110] [Deepro Mukerjee] [Entered: 11/16/2022 03:26 PM] (3) |
| Nov 16, 2022 | 9 | Certificate of Interest for Appellees Apotex Inc. and Apotex Corp.. Service: 11/16/2022 by email. [884509] [23-1110] [Deepro Mukerjee] [Entered: 11/16/2022 03:24 PM] (4) |
| Nov 16, 2022 | 8 | Entry of Appearance for Deepro Mukerjee;Lance Soderstrom;Jitendra Malik;Joseph Janusz;Christopher Ferenc as counsel for Appellees Apotex Inc. and Apotex Corp.. Service: 11/16/2022 by email. [884502] [23-1110] [Deepro Mukerjee] [Entered: 11/16/2022 03:19 PM] (3) |
| Nov 16, 2022 | 7 | Docketing Statement for the Appellee Slayback Pharma LLC. Service: 11/16/2022 by email. [884474] [23-1110] [Constance Huttner] [Entered: 11/16/2022 02:14 PM] (2) |
| Nov 16, 2022 | 6 | Certificate of Interest for Appellee Slayback Pharma LLC. Service: 11/16/2022 by email. [884472] [23-1110] [Constance Huttner] [Entered: 11/16/2022 02:13 PM] (3) |
| Nov 16, 2022 | 5 | Entry of Appearance for Constance S. Huttner; Roy Wepner; Jason Lief; Beth Finkelstein as counsel for Appellee Slayback Pharma LLC. Service: 11/16/2022 by email. [884471] [23-1110] [Constance Huttner] [Entered: 11/16/2022 02:12 PM] (2) |
| Nov 16, 2022 | 4 | Docketing Statement for the Appellant Eagle Pharmaceuticals, Inc.. Service: 11/16/2022 by email. [884459] [23-1110] [Daniel Brown] [Entered: 11/16/2022 01:50 PM] (3) |
| Nov 16, 2022 | 3 | Certificate of Interest for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/16/2022 by email. [884457] [23-1110] [Daniel Brown] [Entered: 11/16/2022 01:48 PM] (2) |
| Nov 16, 2022 | 2 | Entry of appearance for Daniel G. Brown;Gregory G. Garre;Gabriel K. Bell;Michael Clemente;David F. Kowalski as counsel for Appellant Eagle Pharmaceuticals, Inc.. Service: 11/16/2022 by email. [884456] [23-1110] This document is non-compliant. See Doc No. [13] [Daniel Brown] [Entered: 11/16/2022 01:45 PM] (2) |
| Nov 2, 2022 | 1 | Appeal docketed. Received: 10/27/2022. [881790]Entry of Appearance due 11/16/2022. Certificate of Interest is due on 11/16/2022. Docketing Statement due 11/16/2022. Appellant/Petitioner's brief is due 01/03/2023. [KMH] [Entered: 11/02/2022 03:04 PM] (43) |
